Intracellular Lifestyles and immune evasion strategies of uropathogenic Escherichia coli

Annual Review of Microbiology

Volumn 64, Issue , 2010, Pages 203-221

  Hunstad, David A ^a   Justice, Sheryl S ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

biofilm; community; epithelium; neutrophil; urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT; FORSKOLIN;

ADAPTIVE IMMUNITY; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BIOFILM; BLADDER EPITHELIUM; CELL ADHESION; CYSTITIS; CYTOPLASM; EPITHELIUM CELL; EXPERIMENTAL MODEL; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MICROBIAL COMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SEX RATIO; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANIMALS; CYTOPLASM; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; IMMUNE EVASION; MODELS, BIOLOGICAL; RECURRENCE; URINARY TRACT; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 77957961683     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.112408.134258     Document Type: Review

References (110)

1. Alteri CJ, Smith SN, Mobley HL. 2009. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog. 5:e1000448
2. Andersen-Nissen E, Hawn TR, Smith KD, NachmanA, Lampano AE,etal. 2007. Cutting edge: Tlr5-/-mice are more susceptible to Escherichia coli urinary tract infection. J. Immunol. 178:4717-20
3. Anderson GG, O'Toole GA. 2008. Innate and induced resistance mechanisms of bacterial biofilms. Curr. Top. Microbiol. Immunol. 322:85-105
4. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. 2003. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105-7
5. Andriole VT, Patterson TF. 1991. Epidemiology, natural history, and management of urinary tract infections in pregnancy. Med. Clin. North Am. 75:359-73
6. Artifoni L, Negrisolo S, Montini G, Zucchetta P, Molinari PP, et al. 2007. Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J. Urol. 177:1102-6
7. Ashkar AA, Mossman KL, Coombes BK, Gyles CL, Mackenzie R. 2008. FimH adhesin of type 1 fimbriae isapotent inducerofinnate antimicrobial responses which requires TLR4 and type1interferon signaling. PLoS Pathog. 4:e1000233
8. Bahrani-Mougeot FK, Buckles EL, Lockatell CV, Hebel JR, Johnson DE, et al. 2002. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol. Microbiol. 45:1079-93
9. Bergsten G, Wullt B, Schembri MA, Leijonhufvud I, Svanborg C. 2007. Do type 1 fimbriae promote inflammation in the human urinary tract? Cell Microbiol. 9:1766-81
10. Berry RE, Klumpp DJ, Schaeffer AJ. 2009. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect. Immun. 77:2762-72
11. Billips BK, Forrestal SG, Rycyk MT, Johnson JR, Klumpp DJ, Schaeffer AJ. 2007. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect. Immun. 75:5353-60
12. Billips BK, Schaeffer AJ, Klumpp DJ. 2008. Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect. Immun. 76:3891-900
13. Bishop BL, Duncan MJ, Song J, Li G, Zaas D, Abraham SN. 2007. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat. Med. 13:625-30
14. Brauner A, Jacobson SH, Kuhn I. 1992. Urinary Escherichia coli causing recurrent infections\-a prospective follow-up of biochemical phenotypes. Clin. Nephrol. 38:318-23
15. Cass AS, Ireland GW. 1985. Antibacterial perineal washing for prevention of recurrent urinary tract infections. Urology 25:492-94
16. Champion JA, Mitragotri S. 2006. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. USA 103:4930-34
17. Chassin C, Vimont S, Cluzeaud F, Bens M, Goujon JM, et al. 2008. TLR4 facilitates translocation of bacteria across renal collecting duct cells. J. Am. Soc. Nephrol. 19:2364-74
18. Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, et al. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12:636-41
19. Cirl C, Wieser A,Yadav M,Duerr S,Schubert S, et al. 2008. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat. Med. 14:399-406
20. Croxen MA, Finlay BB. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8:26-38
21. Czaja CA, Stamm WE, Stapleton AE, Roberts PL, Hawn TR, et al. 2009. Prospective cohort study of microbial and inflammatory events immediately precedingEscherichia coli recurrent urinary tract infection in women. J. Infect. Dis. 200:528-36
22. Davis JM, Carvalho HM, Rasmussen SB, O'Brien AD. 2006. Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect. Immun. 74:4401-8
23. Davis JM, Rasmussen SB, O'Brien AD. 2005. Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function. Infect. Immun. 73:5301-10
24. Dodson KW, Jacob-Dubuisson F, Striker RT, Hultgren SJ. 1993. Outer-membrane PapC molecular usher discriminately recognizes periplasmic chaperone-pilus subunit complexes. Proc. Natl. Acad. Sci. USA 90:3670-74
25. Doye A, Mettouchi A, Bossis G, Clement R, Buisson-Touati C, et al. 2002. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell 111:553-64
26. Duncan MJ, Li G, Shin JS, Carson JL, Abraham SN. 2004. Bacterial penetration of bladder epithelium through lipid rafts. J. Biol. Chem. 279:18944-51
27. Eschenbach DA, Patton DL, Hooton TM, Meier AS, Stapleton A, et al. 2001. Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium. J. Infect. Dis. 183:913-18
28. Eto DS, Gordon HB, Dhakal BK, Jones TA, Mulvey MA. 2008. Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells. Cell Microbiol. 10:2553-67
29. Eto DS, Jones TA, Sundsbak JL, Mulvey MA. 2007. Integrin-mediated host cell invasion by Type 1-piliated uropathogenic Escherichia coli. PLoS Pathog. 3:e100
30. Eto DS, Sundsbak JL, Mulvey MA. 2006. Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol. 8:704-17
31. Fischer H, Ellstrom P, Ekstrom K, Gustafsson L, Gustafsson M, Svanborg C. 2007. Ceramide as a TLR4 agonist; a putative signaling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell Microbiol. 9:1239-51
32. Flanigan TP, Hogan JW, Smith D, Schoenbaum E, Vlahov D, et al. 1999. Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection. Clin. Infect. Dis. 29:608-12
33. Foxman B. 2003. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49:53-70 (Pubitemid 36350775)
34. Garofalo CK, Hooton TM, Martin SM, Stamm WE, Palermo JJ, et al. 2007. Escherichia coli from urine of females suffering from urinary tract infections are competent for Ibc-formation. Infect. Immun. 75:52-60
35. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg Edén C. 1984. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 46:839-44
36. Hannan TJ, Mysorekar IU, Chen SL, Walker JN, Jones JM, et al. 2008. LeuX tRNA-dependent and-independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol. Microbiol. 67:116-28
37. Hawn TR, Scholes D, Li SS, Wang H, Yang Y, et al. 2009. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 4:e5990
38. Hedges S, Anderson P, Lidin-Janson G, de Man P, Svanborg C. 1991. Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect. Immun. 59:421-27
39. Hedlund M, Frendeus B, Wachtler C, Hang L, Fischer H, Svanborg C. 2001. Type 1 fimbriae deliver an LPS-and TLR4-dependent activation signal to CD14-negative cells. Mol. Microbiol. 39:542-52
40. Hilbert DW, Pascal KE, Libby EK, Mordechai E, Adelson ME, Trama JP. 2008. Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide-and Toll-like receptor 4-independent pathway. Microbes Infect. 10:114-21
41. Hopkins WJ, Elkahwaji J, Kendziorski C, Moser AR, Briggs PM, Suhs KA. 2009. Quantitative trait loci associated with susceptibility to bladder and kidney infections induced by Escherichia coli in female C3H/HeJ mice. J. Infect. Dis. 199:355-61
42. Hunstad DA, Justice SS, Hung CS, Lauer SR, Hultgren SJ. 2005. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect. Immun. 73:3999-4006
43. Ingersoll MA, Kline KA, Nielsen HV, Hultgren SJ. 2008. G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell Microbiol. 10:2568-78
44. Jeannin P, Magistrelli G, Goetsch L, Haeuw JF, Thieblemont N, et al. 2002. Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells impact on vaccine strategies. Vaccine 20(Suppl. 4):A23-27
45. Jost SP. 1989. Cell cycle of normal bladder urothelium in developing and adult mice. Virchows. Arch. B Cell Pathol. Incl. Mol. Pathol. 57:27-36
46. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, et al. 2004. From the cover: differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA 101:1333-38
47. Justice SS, Hunstad DA, Cegelski L, Hultgren SJ. 2008. Morphological plasticity as a bacterial survival strategy. Nat. Rev. Microbiol. 6:162-68
48. Justice SS, Hunstad DA, Harper JR, Duguay AR, Pinkner JS, et al. 2005. Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli. J. Bacteriol. 187:7680-86
49. Justice SS, Hunstad DA, Seed PC, Hultgren SJ. 2006. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc. Natl. Acad. Sci. USA 103:19884-89
50. Justice SS, Lauer SR, Hultgren SJ, Hunstad DA. 2006. Maturation of intracellular Escherichia coli communities requires SurA. Infect. Immun. 74:4793-800
51. Kang WS, Tamarkin FJ, Wheeler MA, Weiss RM. 2004. Rapid up-regulation of endothelial nitric-oxide synthase in a mouse model of Escherichia coli lipopolysaccharide-induced bladder inflammation. J. Pharmacol. Exp. Ther. 310:452-58
52. Klumpp DJ, Rycyk MT, Chen MC, Thumbikat P, Sengupta S, Schaeffer AJ. 2006. Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect. Immun. 74:5106-13
53. Klumpp DJ, Weiser AC, Sengupta S, Forrestal SG, Batler RA, Schaeffer AJ. 2001. Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB. Infect. Immun. 69:6689-95
54. Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ. 2009. QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Mol. Microbiol. 73:1020-31
55. Kouokam JC, Wai SN, Fallman M, Dobrindt U, Hacker J, Uhlin BE. 2006. Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli. Infect. Immun. 74:2022-30
56. Kulesus RR, Diaz-Perez K, Slechta ES, Eto DS, Mulvey MA. 2008. Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli. Infect. Immun. 76:3019-26
57. Lane MC, Alteri CJ, Smith SN, Mobley HL. 2007. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc. Natl. Acad. Sci. USA 104:16669-74
58. Lane MC, Lockatell V, Monterosso G, Lamphier D, Weinert J, et al. 2005. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect. Immun. 73:7644-56
59. Li B, Smith P, Horvath DJ, Romesburg F, Justice SS. 2010. SOS regulatory elements are essential for UPEC pathogenesis. Microbes Infect. doi:10.1016/j.micinf.2010.04.009
60. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, et al. 2005. Urologic Diseases in America Project: analytical methods and principal findings. J. Urol. 173:933-37
61. Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, Karpman D, Andersson B, Svanborg C. 2007. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J. Infect. Dis. 195:1227-34
62. Lundstedt AC, McCarthy S, Gustafsson MC, Godaly G, Jodal U, et al. 2007. A genetic basis of susceptibility to acute pyelonephritis. PLoS One 2:e825
63. Martinez JJ, Hultgren SJ. 2002. Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli. Cell Microbiol. 4:19-28
64. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ. 2000. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 19:2803-12
65. Miyazaki J, Ba-Thein W, Kumao T, Obata Yasuoka M, Akaza H, Hayshi H. 2002. Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells. FEMS Immunol. Med. Microbiol. 33:23-26
66. Monds RD, O'Toole GA. 2009. The developmental model of microbial biofilms: ten years of a paradigm up for review. Trends Microbiol. 17:73-87
67. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, et al. 1998. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494-97
68. Mulvey MA, Schilling JD, Hultgren SJ. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69:4572-79
69. Mysorekar IU, Hultgren SJ. 2006. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl. Acad. Sci. USA 103:14170-75
70. Mysorekar IU, Mulvey MA, Hultgren SJ, Gordon JI. 2002. Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli. J. Biol. Chem. 277:7412-19
71. Nicholson TF, Watts KM, Hunstad DA. 2009. OmpA of uropathogenic Escherichia coli promotes postin-vasion pathogenesis of cystitis. Infect. Immun. 77:5245-51
72. Nicolle LE. 2005. Catheter-related urinary tract infection. Drugs Aging 22:627-39
73. Peck A, Mellins ED. 2010. Precarious balance: Th17 cells in host defense. Infect. Immun. 78:32-38
74. Pernthaler J. 2005. Predation on prokaryotes in the water column and its ecological implications. Nat. Rev. Microbiol. 3:537-46
75. Pichon C, Hechard C, du Merle L, Chaudray C, Bonne I, et al. 2009. Uropathogenic Escherichia coli AL511 requires flagellum to enter renal collecting duct cells. Cell Microbiol. 11:616-28
76. Poljakovic M, Persson K. 2003. Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide. Am. J. Physiol. Renal Physiol. 284:F22-31
77. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-88
78. Pratt LA, Kolter R. 1998. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol. Microbiol. 30:285-93
79. Ragnarsdottir B, Samuelsson M, Gustafsson MC, Leijonhufvud I, Karpman D, Svanborg C. 2007. Reduced Toll-like receptor4 expressioninchildren with asymptomatic bacteriuria.J. Infect. Dis. 196:475-84
80. Roelofs JJ, Teske GJ, Bonta PI, de Vries CJ, Meijers JC, et al. 2009. Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis. Kidney Int. 75:52-59
81. Ronald A, Ludwig E. 2001. Urinary tract infections in adults with diabetes. Int. J. Antimicrob. Agents 17:287-92
82. Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ. 2007. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 4:e329
83. Rosen DA, Pinkner JS, Jones JM, Walker JN, Clegg S, Hultgren SJ. 2008. Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect. Immun. 76:3337-45
84. Russo TA, Stapleton A, Wenderoth S, Hooton TM, Stamm WE. 1995. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J. Infect. Dis. 172:440-45
85. Sabri M, Houle S, Dozois CM. 2009. Roles of the extraintestinal pathogenic Escherichia coli ZnuACB and ZupT zinc transporters during urinary tract infection. Infect. Immun. 77:1155-64
86. Samuelsson P, Hang L, Wullt B, Irjala H, Svanborg C. 2004. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect. Immun. 72:3179-86
87. Schilling JD, Lorenz RG, Hultgren SJ. 2002. Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect. Immun. 70:7042-49
88. Schilling JD, Mulvey MA, Vincent CD, Lorenz RG, Hultgren SJ. 2001. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J. Immunol. 166:1148-55
89. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. 2000. Risk factors for recurrent urinary tract infection in young women. J. Infect. Dis. 182:1177-82
90. Shahin RD, Engberg I, Hagberg L, Svanborg Edén C. 1987. Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J. Immunol. 138:3475-80
91. Sivick KE, Mobley HL. 2009. An "omics" approach to uropathogenic Escherichia coli vaccinology. Trends Microbiol. 17:431-32
92. Sivick KE, Mobley HL. 2010. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect. Immun. 78:568-85
93. Snyder JA, Lloyd AL, Lockatell CV, Johnson DE, Mobley HL. 2006. Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect. Immun. 74:1387-93
94. Song J, Abraham SN. 2008. TLR-mediated immune responses in the urinary tract. Curr. Opin. Microbiol. 11:66-73
95. Song J, Bishop BL, Li G, Duncan MJ, Abraham SN. 2007. TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 1:287-98
96. Song J, Bishop BL, Li G, Grady R, Stapleton A, Abraham SN. 2009. TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc. Natl. Acad. Sci. USA 106:14966-71
97. Song J, Duncan MJ, Li G, Chan C, Grady R, et al. 2007. A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog. 3:e60
98. Svensson M, Irjala H, Alm P, Holmqvist B, Lundstedt AC, Svanborg C. 2005. Natural history of renal scarring in susceptible mIL-8Rh-/-mice. Kidney Int. 67:103-10
99. Svensson M, Irjala H, Svanborg C, Godaly G. 2008. Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection. Kidney Int. 74:81-90
100. Szabados F, Kleine B, Anders A, Kaase M, Sakinc T, et al. 2008. Staphylococcus saprophyticus ATCC 15305 is internalized into human urinary bladder carcinoma cell line 5637. FEMS Microbiol. Lett. 285:163-69
101. Terada N, Ohno N, Saitoh S, Saitoh Y, Fujii Y, et al. 2009. Involvement of dynamin-2 in formation of discoid vesicles in urinary bladder umbrella cells. Cell Tissue Res. 337:91-102
102. Thumbikat P, Berry RE, Schaeffer AJ, Klumpp DJ. 2009. Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli. Microbes Infect. 11:57-65
103. ThumbikatP,Berry RE, ZhouG,Billips BK, Yaggie RE,et al. 2009. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog. 5:e1000415
104. Vertommen D, Ruiz N, Leverrier P, Silhavy TJ, Collet JF. 2009. Characterization of the role of the Escherichia coli periplasmic chaperone SurA using differential proteomics. Proteomics 9:2432-43
105. Vogel SN, Johnson D, Perera PY, Medvedev A, Lariviere L, et al. 1999. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. J. Immunol. 162:5666-70
106. Wright KJ, Hultgren SJ. 2006. Sticky fibers and uropathogenesis: bacterial adhesins in the urinary tract. Future Microbiol. 1:75-87
107. Wright KJ, Seed PC, Hultgren SJ. 2005. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect. Immun. 73:7657-68
108. Wright KJ, Seed PC, Hultgren SJ. 2007. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol. 9:2230-41
109. ZhangD, ZhangG,Hayden MS, Greenblatt MB, Bussey C, et al. 2004.A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522-26
110. Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, et al. 2001. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J. Cell Sci. 114:4095-103